[1]
S. N. Davison, MD, MHSc (bioethics), FRCP(C) and P. R. Mayo, PhD, SFO, “Pain management in chronic kidney disease: The pharmacokinetics and pharmacodynamics of hydromorphone and hydromorphone-3-glucuronide in hemodialysis patients”, J of Opioid Management, vol. 4, no. 6, pp. 335–344, Jan. 2018.